ANNE TSAO to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications ANNE TSAO has written about TOR Serine-Threonine Kinases.
Connection Strength
0.034
-
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM). J Thorac Oncol. 2015 Feb; 10(2):387-91.
Score: 0.019
-
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39.
Score: 0.015